Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4241 Target Snapshot

Squalene monooxygenase · SINGLE PROTEIN · Rattus norvegicus

65Compounds
12Assays
1Approved Drugs
65.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P52020. Use UniProt P52020 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P52020 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Squalene monooxygenase as ChEMBL target CHEMBL4241, mapped to UniProt P52020. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Squalene monooxygenase
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL4241
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P52020
Squalene monooxygenase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Squalene monooxygenase is the right protein anchor across sources, using UniProt P52020 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSqualene monooxygenase
UniProt AccessionP52020
Component TypeProtein
Sequence Length573 aa

Squalene monooxygenase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Squalene monooxygenase, mapped to UniProt P52020. Sequence length is 573 aa.

Mapped IDP52020
Review nameSqualene monooxygenase
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase III
2
Phase II
Assay Mix

Activity Type Distribution

IC5065.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL434998 9.3 IC50 0.5 Preclinical
CHEMBL336565 9.18 IC50 0.66 Preclinical
CHEMBL134888 9.06 IC50 0.87 Preclinical
CHEMBL337391 8.74 IC50 1.8 Preclinical
CHEMBL133373 8.35 IC50 4.5 Preclinical
CHEMBL16121 7.21 IC50 61.0 Preclinical
CHEMBL86248 6.96 IC50 110.0 Preclinical
CHEMBL349197 6.89 IC50 130.0 Preclinical
CHEMBL382408 6.33 IC50 470.0 Preclinical
CHEMBL39504 6.27 IC50 540.0 Preclinical
Distribution

pChEMBL Value Distribution

12
5.0
9
5.5
10
6.0
2
6.5
2
7.0
0
7.5
1
8.0
1
8.5
3
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

12
Total Assays
60
Tested Compounds
1
Assay Types
Binding — 12 assays, 60 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 5 40 5.7
single protein format 3 15 5.7
organism-based format 2 0
cell-based format 1 1 5.2
tissue-based format 1 4 5.2

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine